mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.3 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.3 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.3 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |